et al., 1993 BPC-157 Structure CAS # 137525-51-0 Molecular Formula CHNO Molecular Weight 1419.556 g/mol PubChem ID 108101 Key Areas of Investigation BPC-157 has been evaluated across tendon, ligament, muscle, skin, gastrointestinal, vascular, and cellular-stress models
Integrated Research Applications Cagrilintide is investigated across several metabolic and endocrine research areas: Obesity and energy balance: Clinical and preclinical studies show substantial bodyweight reductions and decreased calorie intake when Cagrilintide is administered alone
Poor filtration, dehydration, low buffering capacity, impaired adenosine metabolism and reduced kidney reserve may all contribute to this bottleneck
This points to the possibility that the peptide could influence extracellular matrix maintenance, hydration, and skin barrier strength in laboratory settings